ΔEPMATIKH EΞΕTAΣH ΓIA ΦYMATIΩΣH ΣE ANOΣOKATAΣTAΛMENA ATOMA

CY1125740T1Undetermined Publication Date: 2026-04-17STATENS SERUM INSTITUT
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20221100783T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2016-02-01
Filing Date
2022-12-13
Publication Date
2026-04-17
Estimated Expiration
2042-12-13
Patent Text Reader

Abstract

The present invention discloses the use of Mycobacterium tuberculosis antigens for use in the in vivo determination of the presence of Mtb infection in immunocompromised individuals or individuals co-infected with HIV and for the preparation of a diagnostic reagent for skin testing (a skin test reagent) for the reliable determination of the presence of Mtb infection in an individual, wherein the individual is an immunocompromised individual or an individual co-infected with HIV.
Need to check novelty before this filing date? Find Prior Art